OVERVIEW

BUSINESS REVIEW, PROSPECTS AND FUTURE PLAN

 

  Since early 2020, the outbreak of Coronavirus Disease 2019 (the “COVID-19”) has spread throughout the world. Every countries had implemented different levels of disease prevention measures, including lockdown and quarantine policies.

 

  The COVID-19 outbreak has adversely affected business and economic activities worldwide significantly. Hang Seng Index dropped substantially from the peak of 29,174 points in January

2020 to the bottom of 21,139 points in March 2020. Nevertheless, the Hang Seng Index have dramatically ramped back up following steep declines closed at 27,231 points on the last trading day of

the year 2020.

 

  However, the external environment is of high relevance to the economy and financial market in Hong Kong. In term of the economic setback of Hong Kong and slow growth projection of China and the COVID-19 outbreak is not abated, the Group expects it is full of challenges in 2021.

 

  The Group expected COVID-19 outbreak will continue to affect the Group’s financial performance for the coming year. The Group will closely monitor the development of the COVID-19 outbreak and continue to evaluate its impact on our business, financial position and operating results.

 

  Looking ahead to the year 2021, the Company will stay in focus to invest in trading securities, private equity funds and private enterprises with potential prospect. Our approach will keep timely and appropriate investment strategies in response to the volatile market, in order to enhance our investment portfolio and achieve net asset appreciation. The Board will pay close attention to the macro trends and keep seeking opportunities to invest in China, Hong Kong and overseas. The Company will continue to implement its risk management policy with an aim to achieve stable returns on investments for our shareholders.